Human cytomegalovirus (CMV) remains the most common infection affecting organ transplant recipients. Despite advances in the prophylaxis and acute treatment of CMV, it remains an important pathogen affecting the short- and long-term clinical outcome of solid organ transplant recipient. The emergence of CMV resistance in a patient reduces the clinical efficacy of antiviral therapy, complicates t...

Introduction: With the Covid-19 pandemic, many medical procedures underwent significant changes due to reallocation of resources patients infected with Sars-Cov-2. The logistics transplants were directly affected, important repercussions for patient on waiting list a new organ. Objective: This review seeks analyze impact pandemic solid organ availability and volume transplants. Methods: An inte...

Toxoplasmosis in organ transplant patients can be a result of donor-transmitted infection, or reactivation of latent infection, or de novo infection. Solid organ transplants including heart, liver, kidney, pancreas and small bowel, and hematogenous stem cell transplants have been implicated in the risk of acquiring infection. In contrast to a benign course in immunocompetent individuals, the sp...

Aim: Considering that the correct diagnosis and management of patients with brain death in intensive care units is the basis of the transplant system and considering the importance of nursing care in the organ transplant process, this study aimed to investigate the nurses’ performance of critical wards with organ donation. Materials & Methods: This is a cross-sectional study performed in Educa...

Mucormycosis is the third most common invasive fungal infection with a high mortality rate seen in immunocompromised patients. It an increasingly well-reported that affects recipients of solid-organ transplant. The incidence mucormycosis patients heart transplants ranges from 0 to 0.6%. We reported case young transplant male recipient.

Transplantation is an effective, life-prolonging treatment for organ failure. Demand has steadily increased over the past decade, creating a shortage in the supply of organs. In addition, the number of deceased organ donors has reached a plateau. Living-donor transplantation is increasingly an option, influenced by favourable clinical outcomes and increased waiting times at most transplant cent...

Organ donation is an integral part of the health care system. Many patients who have had an accident or have undergone a progressive disease are in need of an organ transplant and if they do not receive the required organ they would die. It is important to know that the most important source of organ donation is the brain death patients. It is highly essential to determine the pivotal factors t...

Organ transplantation is an expensive, life-saving technology. Previous studies have found that few transplant recipients in the United States lack health insurance (in part because patients may become eligible for special coverage because of their disability and transplant teams vigorously advocate for their patients). Few data are available on the insurance status of U.S. organ donors. The au...